• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Autologous CD34+ cell transplantation promotes angiogenesis in older adult patients with atherosclerotic ischemia: study protocol for a randomized controlled trial

    2017-04-09 08:18:33LiliXuChenhongZhouXiaojieTanMingjinGuoLikunZhangPeiZhangBingLiu

    Li-li Xu, Chen-hong Zhou, Xiao-jie Tan, Ming-jin Guo, Li-kun Zhang, Pei Zhang, Bing Liu*

    Qingdao No. 9 People’s Hospital, Qingdao, Shandong Province, China

    INTRODUCTION

    History and current related studies

    Arteriosclerosis obliterans is an example of arterial lumen stenosis and occlusive disease, which is caused by the continuous expansion of arterial atherosclerosis and secondary thrombosis. Clinical manifestations are local skin temperature reduction, intermittent claudication, rest pain, difficult to heal ulcers, and gangrene infection.1,2Some patients require amputation, and the condition can be life-threatening for some. Arteriosclerosis obliterans of the lower limbs are commonly treated by surgical, endovascular or non-surgical methods, but none of them is completely satisfactory.3-5

    Stem cell transplantation has achieved great progress in angiogenesis and collateral circulation in the treatment of arteriosclerosis obliterans. There are two main mechanisms of stem cell action in angiogenesis: (1) Promoting the differentiation and maturation of new blood vessels by homing and integration of stem cells in the damaged vascular plexus. (2)Promoting angiogenesis in ischemic tissue by the paracrine action of vascular endothelial growth factor (VEGF).6-9The discovery in recent years of endothelial progenitor cells in peripheral blood has renewed the concept of angiogenesis.Transplantation of endothelial progenitor cells and bone marrow cells for angiogenesis has become the focus of research. Endothelial progenitor cell and bone marrow cell transplantation have been used to promote angiogenesis in ischemic tissue to treat limb ischemia.

    Bone marrow stem cell mobilization is used to promote the replication of bone marrow stem cells. This increases the number of endothelial progenitor cells in peripheral blood and the number of stem cells homing on ischemic tissue,thus accelerating the speed and magnitude of angiogenesis.Fujisaki et al.10have confirmed that bone marrow cell mobilizers can significantly stimulate bone marrow hematopoiesis and increase the number of peripheral blood stem cells. Bone marrow cell mobilizer-recombinant human granulocyte colony stimulating factor (rhG-CSF) is used to mobilize bone marrow stem cells to the peripheral blood, and to increase the number of peripheral blood stem cells, especially endothelial progenitor cells. This method of treating ischemic diseases is called autologous stem cell transplantation.11,12However, the proliferation potential and factors influencing the mobilized bone marrow stem cells and peripheral blood endothelial progenitor cells in ischemic tissue require further investigations in animal and human experiments.

    Autologous stem cell transplantation transplants stem cells into the muscles of the ischemic limb so that new capillaries will improve and restore lower limb blood flow and reduce lower limb ischemia. Endothelial progenitor cells and hematopoietic stem cells are thought to come from a common ancestor, blood vessel stem cells. They express immature stem cell markers CD34 and CD133. Endothelial progenitor cells that migrate from bone marrow to peripheral blood will gradually lose CD133, and the disappearance of CD34 is relatively slow. A large number of experimental and a few clinical studies have confirmed that the transplantation of CD34+cells can promote angiogenesis in the ischemic limbs of experimental animals and patients.13,14

    Main objective

    We aim to verify angiogenesis in older adult patients with atherosclerotic ischemia after peripheral blood autologous CD34+cell transplantation.

    METHODS/DESIGN

    Study design

    A prospective, single-center, open-label, randomized and controlled clinical trial.

    Study setting

    Qingdao No. 9 People’s Hospital, Qingdao, Shandong Province, China.

    Study procedures

    (1) Twenty older adult patients with atherosclerotic lower limb ischemia will be randomized into either the cell transplantation group or the control group.

    (2) Bone marrow stem cells will be mobilized by G-CSF.Peripheral blood hematopoietic stem cells will be harvested to extract CD34+cells. CD34+cells will be cultured and identified. VEGF165gene vector will be constructed and transfected into the above CD34+cells.

    (3) In the cell transplantation group (n = 10), peripheral blood CD34+cells transfected with the VEGF165gene will be transplanted into the muscles of ischemic limbs in older adult patients with atherosclerotic lower limb ischemia.In the control group (n = 10), physiological saline will be injected into the muscles of ischemic limbs. Patients will be followed up for 6 months.

    (4) The flow chart of trial protocol is shown in Figure 1.

    Ethical considerations

    The study protocol has been approved by the Ethics Committee of Qingdao No. 9 People’s Hospital of China. All protocols will be in accordance with the Declaration of Helsinki and the ethical requirements of the hospital for human research. The writing and editing of the article will be in accordance with the Standard Protocol Items:Recommendations for Interventional Trials (SPIRIT is shown in Additional file 1). ClinicalTrials.gov identifier:NCT03098771. The participating individuals will participate voluntarily with the consent of their family members.All donors and recipients will be fully informed of the experimental process, and will sign the informed consent after they fully understand the treatment plan.

    Figure 1: Flow chart of trial protocol.

    Study participants

    Inclusion criteria

    Patients presenting with all of the following criteria will be considered for study inclusion.

    ? Older adult patients with arteriosclerosis obliterans(Rutherford classification of class 5: slight tissue defect;class 6: tissue ulceration, gangrene)

    ? Diabetic foot, Wagner classification of class 315: deep ulcer, often affecting bone tissue, with deep abscess or osteomyelitis

    ? Age range: 50–60 years

    ? Either gender

    ? Unilateral limb lesions

    ? Total occlusion of main blood vessels

    ? No outflow tract in distal arteries

    ? Open surgery and endovascular surgery cannot be performed

    ? Signed informed consent

    Exclusion criteria

    Patients with one or more of the following conditions will be excluded from this study.

    ? Moderate to severe liver and kidney dysfunction

    ? Malignant tumor

    ? Hematological system diseases

    ? Rheumatic immune system diseases

    ? Poor stimulating effect on colony stimulating factor

    ? Thromboangiitis obliterans

    ? Severe hyperthyroidism

    ? Endocrine and metabolic diseases such as severe hypothyroidism

    Sample size

    In accordance with our experience, the range of anklebrachial index (ABI; Appendix 1) of normal persons at resting is between 0.9 and 1.3. We hypothesize that the average increase of ABI will be 0.2 and 0.05 in the cell transplantation and control groups, respectively at 6 months postoperation. Standard deviation of ABI will be 0.3. Taking β = 0.1 and Power = 90% with a significance level of α =0.05, the final effective sample size of n = 70 per group will be calculated using PASS 11.0 software (PASS, Kaysville,UT, USA). If we assume a patient loss rate of 20%, we will require 84 patients per group. In this study, we aim to include 10 patients in the cell transplantation group and 10 patients in the control group.CD34+cells. Reverse transplantation-polymerase chain reaction will be utilized to detect VEGF165mRNA expression in CD34+cells. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay will be applied to determine the effects of VEGF165 transfection on CD34+cell proliferation.

    Recruitment

    Inpatients of the Qingdao No. 9 People’s Hospital will be recruited. We will explain in detail the contents of the study and precautions. Potential participants can contact the project manager via telephone. After providing informed consent, these potential participants will be screened using the inclusion and exclusion criteria.

    Randomization and blinding

    A random number table will be generated by a computer.Patients will be numbered and will be arbitrarily determined on the random number table. The 20 patients will be equally and randomly assigned to two groups. Patients, physicians,and assessors will not be blinded to group information or the therapeutic regime.

    Interventions

    Harvesting CD34+ cells

    After mobilization with rhG-CSF for 4 days, peripheral blood hematopoietic stem cells will be harvested from patients using Baxter Fenwal CS-3000 Plus Blood Cell Separator, and centrifuged with Ficoll (relative density of 1.007). Mononuclear cells will be collected and incubated on HFN-coated plates with M199 medium containing fetal bovine serum and VEGF for 7 days. Cells will be incubated with CD34-PE-labeled monoclonal antibody at room temperature for 15 minutes. Flow cytometry will be used to determine and mobilize CD34+cells in hematopoietic stem cells after incubation. Cells will be processed using CliniMACS CD34 Reagent System.

    Identification of CD34+ cells

    The morphology of adherent cells will be observed under an inverted microscope. Adherent cells labeled with DiI-acLDL and FITC-UEA-I will be observed with laser scanning confocal microscope.

    Transfection and identification of VEGF165 gene

    The synthetic VEGF165gene sequence will be cloned into 55pCR2.1-TOPO vector. After checking with sequencing,the sample will be cloned into the eukaryotic expression vector pcDNA3.1(+) to construct recombinant plasmid pcDNA3.1(+)/VEGF165. The pcDNA3.1-hVEGF165plasmid will be amplified and extracted, identified with double enzyme digestion and sequencing, and then transfected into

    Cell transplantation

    VEGF165-transfected CD34+cells (1 × 106/L, 10 mL in one limb) will be intramuscularly injected into the ischemic limb in the cell transplantation group. Physiological saline (10 mL) will be intramuscularly injected into the control group. The injection will be carried out at 10 sites in both groups.

    Outcome measures

    Primary outcome measure

    The ratio of the blood pressure at the ankle to the blood pressure in the upper arm (ABI) will be used to assess lower limb ischemia before and 6 months after transplantation in both groups.

    The range of ABI of normal persons at rest is between 0.9 and 1.3. Abnormal results: less than 0.8 represents moderate arteriosclerosis obliterans; less than 0.5 represents severe arteriosclerosis obliterans. The ABI of intermittent claudication patients is mainly between 0.35 and 0.9. The ABI of rest pain patients is often less than 0.4, and the patient will be at risk of amputation. ABI of more than 1.3 indicates vascular wall calcification and loss of vascular contraction.

    Secondary outcome measures

    The number of microvessels in the lower limb muscles before and 6 months after transplantation: Immunohistochemical staining will be measured in five fields, randomly selected under a high power microscope (× 400). A higher number of microvessels after 6 months indicates the generation of more new blood vessels.

    Morphology of new blood vessels: The morphology will be revealed by CT angiography before and 6 months after transplantation:

    The number of VEGF-immunoreactive cells: Immunohistochemical staining will be applied to observe cell number 6 months after transplantation. A high number of VEGF-immunoreactive cells indicates more new blood vessels.

    Incidence of adverse reactions: Postoperative complications will be recorded after the 6 months of transplantation to evaluate the safety of the procedure.

    The schedule of outcome measurement assessments is shown in Table 1.

    Table 1: Timing of outcome assessment

    Adverse events

    (1) We will record adverse events, including fever, infection, lower limb pain and ulcers, during follow-ups at the outpatient clinic.

    (2) If severe adverse events occur, investigators will report details, including the date of occurrence and measures taken to treat the adverse events, to the principle investigator and the institutional review board within 24 hours.

    Data collection, management, analysis and open access

    (1) Data collection: Case report forms will be collected and processed using Epidata software (Epidata Association,Odense, Denmark), collated, and recorded electronically using a double-data entry strategy.

    (2) Data management: The locked electronic database will be accessible and locked only by the project manager. This arrangement will not be altered. The Qingdao No. 9 People’s Hospital, China will preserve all data regarding this trial.

    (3) Data analysis: A professional statistician will statistically analyze the electronic database and will create an outcome analysis report that will be submitted to the lead researchers. An independent data monitoring committee will supervise and manage the trial data, ensuring a scientific and stringent trial that yields accurate and complete data.

    (4) Data open access: Anonymized trial data will be published at www.figshare.com.

    Statistical analysis

    (1) Statistical analysis will be performed using SPSS 19.0 software (IBM, Armonk, NY, USA) and will follow the intention-to-treat principle.

    (2) Normally distributed measurement data will be expressed as means, standard deviation, minimums and maximums. Non-normally distributed measurement data will be expressed as the lower quartile (q1), median and upper quartiles (q3). Count data will be expressed as a percentage of adverse reaction.

    (3) Kolmogorov-Smirnov test will be used to determine the normality of measurement data. If data obey the normal distribution, ABI, the number of microvessels in the lower limb muscles and the number of VEGF-immunoreactive cells will be compared using a two-sample t-test between the two groups. Intragroup difference of above indicators will be compared using paired t-test before and 6 months after transplantation. If data do not obey the normal distribution,intergroup and intragroup data will be compared using the Mann-Whitney U test and the Wilcoxon signed-rank test.The incidence of adverse reactions will be compared with Fisher’s exact probability test between the two groups 6 months after transplantation.

    (4) The significance level will be α = 0.05.

    TRIAL STATUS

    The trial is in the design stage. Subject recruitment is scheduled to start in January 2018. The primary outcome measure analysis, and all tests will be finished in December 2019.

    DISCUSSION

    Characteristics of this study

    Few studies concern CD34+cell transplantation in the treatment of lower limb ischemia in loder adults. An in-depth investigation of the effects of VEGF165-modified CD34+cell transplantation for treating this condition in older adults will help to develop a new model of treatment. Gene transfection,in vivo CD34+cell transplantation, immunohistochemical staining and CT angiography will be used to explore the effects of VEGF165-modified CD34+cell transplantation for treating senile atherosclerotic lower extremity ischemia.

    Limitations of this study

    The small sample size and limited follow-up will affect the reliability of the results in this preliminary study. Sample size will be increased in future studies.16-18

    Significance of this study

    This trial aims to test the efficacy and safety of CD34+cell transplantation for treating senile atherosclerotic lower extremity ischemia.

    Appendix 1 Indications of ankle-brachial index (ABI)

    In the primary care setting, an ABI is useful in the follow

    ing 2 settings:

    ? In a symptomatic patient, to diagnose peripheral arterial disease (PAD)

    ? In an asymptomatic patient, to assess the vascular risk for PAD

    In the emergency or trauma setting, an ABI is useful for the evaluation of a patient who is at increased risk for lowerextremity arterial injury, as follows:

    ? An ABI less than 0.90 suggests a need for further vascular imaging: angiography in a stable patient, and operative exploration in an unstable patient

    ? An ABI greater than 0.90 decreases the likelihood of an arterial injury; thus, the patient may be observed with serial ABI assessments or may undergo a vascular study on a delayed basis

    Addltional flie

    Addltional flie 1: SPIRIT checklist (PDF 48.1 kb).

    Declaration of patient consent

    The authors certify that they will obtain all appropriate patient consent forms. In the form the patients will give their consent for their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

    Conflicts of interest

    None declared.

    Author contributions

    Study concept and design, drafting of the manuscript, study supervision and final approval: CHZ. Experiment implement: CHZ,XJT, LLX, MJG, BL and PZ.

    Plagiarism check

    This paper was screened twice using CrossCheck to verify originality before publication.

    Peer review

    This paper was double-blinded and stringently reviewed by international expert reviewers.

    1. Rodrigues CG, Plentz RD, Dipp T, et al. VEGF 165 gene therapy for patients with refractory angina: mobilization of endothelial progenitor cells. Arq Bras Cardiol. 2013;101:149-153.

    2. Cangiano E, Cavazza C, Campo G, et al. Different clinical models of CD34+cells mobilization in patients with cardiovascular disease. J Thromb Thrombolysis. 2011;32:1-8.

    3. Sasaki KI, Chibana H, Ueno T, Itaya N, Sasaki M, Fukumoto Y.Successful endovascular treatment of aortoiliac bifurcation stenosis using an empirically based T and protrude-stenting with self- and balloon-expandable stents. Kurume Med J. 2017. doi:10.2739/kurumemedj.MS6300010.

    4. Zhuang JM, Li X, Li TR, Zhao J, Luan JY, Wang CM. Randomized controlled trial to superficial femoral artery recanalization for lower extremity arteriosclerosis obliterans. Beijing Da Xue Xue Bao Yi Xue Ban. 2017;49:153-157.

    5. 2014 JAPAN Critical Limb Ischemia Database (JCLIMB) Annual Report. Ann Vasc Dis. 2016;9:374-391.

    6. Balbi C, Piccoli M, Barile L, et al. First Characterization of human amniotic fluid stem cell extracellular vesicles as a powerful paracrine tool endowed with regenerative potential. Stem Cells Trans Med. 2017. doi: 10.1002/sctm.16-0297.

    7. Manjunathan R, Ragunathan M. In ovo administration of human recombinant leptin shows dose dependent angiogenic effect on chicken chorioallantoic membrane. Biol Res. 2015;48:29.

    8. Park IS, Chung PS, Ahn JC. Enhancement of ischemic wound healing by spheroid grafting of human adipose-derived stem cells treated with low-level light irradiation. PLoS One. 2015;10:e0122776.

    9. Zhao P, Chen Y, Yue Z, Yuan Y, Wang X. Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway. Leuk Res. 2017;57:20-26.

    10. Fujisaki J, Wu J, Carlson AL, et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stemcell niche. Nature. 2011;474:216-219.

    11. Orrico C, Pasquinelli G, Foroni L, et al. Dysfunctional vasa vasorum in diabetic peripheral artery obstructive disease with critical lower limb ischaemia. Eur J Vasc Endovasc Surg.2010;40:365-374.

    12. Tan K, Lessieur E, Cutler A, et al. Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy. Exp Eye Res. 2010;91:229-237.

    13. Taguchi A. Cell-based therapy for patients with vascular dementia. Psychogeriatrics. 2011;11:113-115.

    14. Yoo CH, Na HJ, Lee DS, et al. Endothelial progenitor cells from human dental pulp-derived iPS cells as a therapeutic target for ischemic vascular diseases. Biomaterials. 2013;34:8149-8160.

    15. Li CH, Chen Y, Zhang CH, et al. Observation of clinical efficacy of rt-PA intravenous thrombolytic treatment for patients combined with grade 0-1 diabetic foot by Wagner classification and acute ischemic stroke. Eur Rev Med Pharmacol Sci.2016;20:5168-5173.

    16. Zhang H, Lei C, Zhang TY, et al. Transcutaneous electri cal acupoint stimulation with different acupoint combinations on opioid consumption in patients undergoing off-pump coronary artery bypass grafting: study protocol for a randomized doubleblind controlled trial. Clin Transl Degener Dis. 2016;1:17-24.

    17. Wang Y. Chinese medicine packet plus wax therapy for periarthritis of the shoulder: study protocol for a multi-center randomized controlled trial. Clin Transl Degener Dis. 2016;1:25-31.

    18. Ma N, Peng J, Guo QY. Local administration of enriched mononuclear cells, platelets and zoledronic acid for preventing collapse of the femoral head in the early stage of osteonecrosis:study protocol for a prospective randomized parallel-controlled clinical trial. Clin Transl Degener Dis. 2016;1:32-37.

    夜夜爽夜夜爽视频| 亚洲欧美一区二区三区黑人 | 亚洲国产日韩一区二区| 亚洲精品亚洲一区二区| 国产精品免费大片| av不卡在线播放| 晚上一个人看的免费电影| 欧美一级a爱片免费观看看| 国产精品一区二区在线观看99| 亚洲av中文av极速乱| 亚洲综合色网址| 最后的刺客免费高清国语| 亚洲av不卡在线观看| 18+在线观看网站| 国产免费一级a男人的天堂| 日本vs欧美在线观看视频| 久久精品久久精品一区二区三区| 欧美 日韩 精品 国产| 欧美激情 高清一区二区三区| 国产女主播在线喷水免费视频网站| av免费在线看不卡| 国产亚洲精品久久久com| 老熟女久久久| 欧美激情极品国产一区二区三区 | 成人漫画全彩无遮挡| 国产老妇伦熟女老妇高清| 国产亚洲精品第一综合不卡 | 一区二区av电影网| 美女福利国产在线| 久久久久久久大尺度免费视频| 亚洲欧美成人精品一区二区| 这个男人来自地球电影免费观看 | av有码第一页| 精品久久久久久电影网| 最近手机中文字幕大全| 亚洲第一av免费看| 岛国毛片在线播放| 中文欧美无线码| 日韩强制内射视频| 久久精品久久久久久久性| 免费看不卡的av| 国产永久视频网站| 久久久久人妻精品一区果冻| 国产视频内射| 亚洲,欧美,日韩| 只有这里有精品99| 久久久久久久精品精品| 18禁观看日本| 国产精品一区二区在线观看99| 亚洲av成人精品一二三区| 亚洲,一卡二卡三卡| 超碰97精品在线观看| 亚洲欧美成人精品一区二区| 婷婷色综合大香蕉| 丝袜美足系列| av黄色大香蕉| 色网站视频免费| 亚洲av成人精品一二三区| 国产精品久久久久久av不卡| 精品亚洲成a人片在线观看| 国产精品一区二区在线观看99| 亚洲怡红院男人天堂| 啦啦啦中文免费视频观看日本| 黄色视频在线播放观看不卡| 久久这里有精品视频免费| 永久免费av网站大全| 日韩大片免费观看网站| 一本大道久久a久久精品| 国产亚洲精品第一综合不卡 | 亚洲精品色激情综合| 亚洲国产最新在线播放| 午夜影院在线不卡| 永久免费av网站大全| 色哟哟·www| 丝袜脚勾引网站| 免费少妇av软件| 精品熟女少妇av免费看| 亚洲欧洲日产国产| 性色av一级| 午夜福利,免费看| 街头女战士在线观看网站| 在线观看国产h片| 亚洲人与动物交配视频| 日韩,欧美,国产一区二区三区| 国产精品无大码| 校园人妻丝袜中文字幕| 久久久久久久久久久丰满| 免费高清在线观看日韩| 亚洲综合色网址| 熟女人妻精品中文字幕| 日韩在线高清观看一区二区三区| 在线观看免费日韩欧美大片 | 欧美激情极品国产一区二区三区 | 成人无遮挡网站| 乱码一卡2卡4卡精品| 夜夜看夜夜爽夜夜摸| 各种免费的搞黄视频| 美女福利国产在线| 精品亚洲成a人片在线观看| 日本-黄色视频高清免费观看| 国产精品人妻久久久影院| 日韩亚洲欧美综合| 亚洲无线观看免费| 亚洲av成人精品一二三区| 少妇猛男粗大的猛烈进出视频| 三级国产精品片| 国产精品一区www在线观看| 久久精品人人爽人人爽视色| 亚洲av成人精品一区久久| a级片在线免费高清观看视频| 久久鲁丝午夜福利片| 亚洲成人av在线免费| 国产黄色免费在线视频| 色婷婷av一区二区三区视频| 成人漫画全彩无遮挡| 老司机亚洲免费影院| 中文字幕免费在线视频6| 国产成人午夜福利电影在线观看| 成人亚洲欧美一区二区av| 久久久午夜欧美精品| 久久久久视频综合| 免费观看性生交大片5| 国内精品宾馆在线| 蜜桃久久精品国产亚洲av| 尾随美女入室| 久久久亚洲精品成人影院| 激情五月婷婷亚洲| 中文字幕亚洲精品专区| 国产成人精品久久久久久| 国产精品免费大片| 高清毛片免费看| 欧美三级亚洲精品| 国产视频首页在线观看| 九九爱精品视频在线观看| 国产成人精品在线电影| 国国产精品蜜臀av免费| 国产爽快片一区二区三区| 国产精品.久久久| 亚洲av.av天堂| 日韩亚洲欧美综合| 亚洲精华国产精华液的使用体验| 欧美人与性动交α欧美精品济南到 | av线在线观看网站| 一级,二级,三级黄色视频| 午夜免费鲁丝| 国产成人精品一,二区| 精品人妻偷拍中文字幕| 综合色丁香网| 男女无遮挡免费网站观看| 国产黄频视频在线观看| 亚洲欧美日韩卡通动漫| 久久精品熟女亚洲av麻豆精品| 亚洲精品久久久久久婷婷小说| 日韩成人av中文字幕在线观看| 九九爱精品视频在线观看| 国产免费福利视频在线观看| 校园人妻丝袜中文字幕| 成年女人在线观看亚洲视频| 中文欧美无线码| 能在线免费看毛片的网站| 一区二区日韩欧美中文字幕 | 99热国产这里只有精品6| 人妻人人澡人人爽人人| 久热这里只有精品99| 亚洲美女搞黄在线观看| 亚洲av欧美aⅴ国产| 中文字幕人妻丝袜制服| 美女脱内裤让男人舔精品视频| 成人亚洲精品一区在线观看| 看十八女毛片水多多多| 国产男女超爽视频在线观看| 波野结衣二区三区在线| 精品国产一区二区三区久久久樱花| 欧美最新免费一区二区三区| 亚洲人成77777在线视频| 国产男女超爽视频在线观看| 国产精品久久久久久久电影| 全区人妻精品视频| 大话2 男鬼变身卡| 男女啪啪激烈高潮av片| 亚洲精品日韩在线中文字幕| 国产极品天堂在线| 国产精品成人在线| 中文欧美无线码| av福利片在线| 精品一区二区免费观看| 极品人妻少妇av视频| 十分钟在线观看高清视频www| 一本色道久久久久久精品综合| 亚洲一级一片aⅴ在线观看| 国产欧美另类精品又又久久亚洲欧美| 黑人高潮一二区| 一区二区三区免费毛片| 91精品国产九色| 亚洲丝袜综合中文字幕| 中文天堂在线官网| √禁漫天堂资源中文www| 色婷婷久久久亚洲欧美| 日本欧美视频一区| 三级国产精品欧美在线观看| 亚洲精品色激情综合| 成人无遮挡网站| 久久久久久久久久久丰满| 国产淫语在线视频| 交换朋友夫妻互换小说| 18禁裸乳无遮挡动漫免费视频| 国产精品久久久久成人av| 国产精品麻豆人妻色哟哟久久| av.在线天堂| 少妇的逼好多水| 亚洲精品第二区| 午夜福利,免费看| 日本午夜av视频| av在线播放精品| 三上悠亚av全集在线观看| 国产欧美亚洲国产| 久久精品久久久久久噜噜老黄| 99久久综合免费| 久久精品国产a三级三级三级| 99视频精品全部免费 在线| av免费在线看不卡| a级毛片黄视频| 免费看不卡的av| 亚洲精品日韩av片在线观看| 国产免费视频播放在线视频| 黑人巨大精品欧美一区二区蜜桃 | 免费大片黄手机在线观看| av福利片在线| 一区二区三区乱码不卡18| 熟妇人妻不卡中文字幕| 亚洲av二区三区四区| 美女国产视频在线观看| 免费日韩欧美在线观看| 青春草视频在线免费观看| 久久久久久久久久久久大奶| 精品一区在线观看国产| 国产亚洲一区二区精品| 亚洲,欧美,日韩| 久久久久精品久久久久真实原创| 亚洲婷婷狠狠爱综合网| 久久国产精品男人的天堂亚洲 | 边亲边吃奶的免费视频| 搡老乐熟女国产| 久久久久久久国产电影| 久久99一区二区三区| 爱豆传媒免费全集在线观看| 在线 av 中文字幕| 精品一区二区三卡| 一级毛片黄色毛片免费观看视频| 久久免费观看电影| 国产亚洲午夜精品一区二区久久| 熟女人妻精品中文字幕| 久久久欧美国产精品| 亚洲在久久综合| 国产黄色免费在线视频| 国产精品国产三级国产av玫瑰| 校园人妻丝袜中文字幕| 丝瓜视频免费看黄片| 久久女婷五月综合色啪小说| 国产精品国产三级国产av玫瑰| 国产片特级美女逼逼视频| 日韩电影二区| 亚洲av国产av综合av卡| 最近中文字幕高清免费大全6| 又黄又爽又刺激的免费视频.| 精品国产露脸久久av麻豆| 成人18禁高潮啪啪吃奶动态图 | 一区在线观看完整版| 精品一区二区三区视频在线| 国产熟女欧美一区二区| videossex国产| 不卡视频在线观看欧美| 精品久久久久久久久av| 日韩视频在线欧美| 日韩精品有码人妻一区| 国产亚洲一区二区精品| 18在线观看网站| 高清欧美精品videossex| 国产成人精品福利久久| 欧美日韩视频高清一区二区三区二| 精品久久久噜噜| 免费播放大片免费观看视频在线观看| 亚洲精品456在线播放app| 中文天堂在线官网| 国产精品久久久久成人av| 国产免费现黄频在线看| 91久久精品国产一区二区成人| 热99久久久久精品小说推荐| 黑人猛操日本美女一级片| 在线观看人妻少妇| 视频区图区小说| 亚洲av综合色区一区| 久久久久久久久久久久大奶| 丝袜脚勾引网站| 国产精品久久久久久久电影| 亚洲综合精品二区| 久久国产精品大桥未久av| 免费观看性生交大片5| 国产精品不卡视频一区二区| 男女国产视频网站| 午夜免费男女啪啪视频观看| 精品久久国产蜜桃| 精品一区二区三卡| 又粗又硬又长又爽又黄的视频| av在线app专区| 少妇丰满av| 超碰97精品在线观看| 亚洲精品日韩在线中文字幕| 少妇 在线观看| 国产成人精品无人区| 亚洲欧美清纯卡通| 免费观看av网站的网址| av电影中文网址| 国产精品一区二区三区四区免费观看| 国产成人av激情在线播放 | 亚州av有码| 蜜桃久久精品国产亚洲av| 制服诱惑二区| 蜜桃国产av成人99| 观看av在线不卡| 国产视频内射| 成人手机av| 狂野欧美白嫩少妇大欣赏| 人妻夜夜爽99麻豆av| 日韩欧美精品免费久久| 最近中文字幕2019免费版| 国产黄片视频在线免费观看| 99国产精品免费福利视频| 91久久精品国产一区二区三区| 国产成人精品一,二区| 久久久久久久久大av| 午夜精品国产一区二区电影| 少妇被粗大猛烈的视频| 女的被弄到高潮叫床怎么办| 欧美人与性动交α欧美精品济南到 | 午夜福利,免费看| 欧美国产精品一级二级三级| 亚洲av在线观看美女高潮| 久久免费观看电影| 国产日韩欧美视频二区| 街头女战士在线观看网站| 国产精品国产三级国产专区5o| 成人毛片a级毛片在线播放| 老司机影院成人| 熟女电影av网| 美女cb高潮喷水在线观看| 国产男女超爽视频在线观看| 一本久久精品| 男女免费视频国产| 成年人午夜在线观看视频| 高清午夜精品一区二区三区| 最近手机中文字幕大全| 三级国产精品欧美在线观看| 黄色视频在线播放观看不卡| 日韩av在线免费看完整版不卡| 精品一区二区三区视频在线| 天天躁夜夜躁狠狠久久av| 成年人午夜在线观看视频| 久久99一区二区三区| 日韩亚洲欧美综合| 国产精品 国内视频| 熟女人妻精品中文字幕| freevideosex欧美| 另类精品久久| 五月伊人婷婷丁香| av线在线观看网站| 亚洲精品乱久久久久久| 亚洲第一av免费看| 夫妻午夜视频| 亚洲无线观看免费| 久久97久久精品| 日本黄色日本黄色录像| 国精品久久久久久国模美| 岛国毛片在线播放| 99九九在线精品视频| 亚洲人成77777在线视频| 亚洲国产最新在线播放| 亚洲欧美一区二区三区黑人 | 一级毛片我不卡| 九九在线视频观看精品| 美女cb高潮喷水在线观看| 亚洲第一区二区三区不卡| 亚洲av免费高清在线观看| 人体艺术视频欧美日本| 日韩亚洲欧美综合| 亚洲精品乱码久久久久久按摩| 亚洲欧美日韩另类电影网站| 大香蕉久久成人网| 国产一级毛片在线| 九九久久精品国产亚洲av麻豆| 丝瓜视频免费看黄片| 美女国产视频在线观看| 夜夜爽夜夜爽视频| 狂野欧美激情性xxxx在线观看| 熟女av电影| 国产日韩一区二区三区精品不卡 | 大片电影免费在线观看免费| 久热这里只有精品99| 亚洲欧洲精品一区二区精品久久久 | 免费高清在线观看视频在线观看| 国产精品久久久久久久久免| 最新中文字幕久久久久| 亚洲人成网站在线播| 九九久久精品国产亚洲av麻豆| videos熟女内射| 中国三级夫妇交换| 成年女人在线观看亚洲视频| 亚洲国产精品一区三区| 亚洲久久久国产精品| 亚洲欧美日韩卡通动漫| 熟女电影av网| 欧美精品亚洲一区二区| 91aial.com中文字幕在线观看| 亚洲成人一二三区av| 久久精品国产自在天天线| av线在线观看网站| 国产成人精品婷婷| 日韩成人伦理影院| 久久国产亚洲av麻豆专区| 女性生殖器流出的白浆| 大香蕉97超碰在线| 22中文网久久字幕| 婷婷成人精品国产| 国产成人91sexporn| 午夜影院在线不卡| 狂野欧美激情性xxxx在线观看| 久久久久久久久久成人| 少妇猛男粗大的猛烈进出视频| 成人亚洲欧美一区二区av| 国产精品熟女久久久久浪| 亚洲精品aⅴ在线观看| 国产黄色视频一区二区在线观看| 制服诱惑二区| 97在线人人人人妻| 又粗又硬又长又爽又黄的视频| 另类亚洲欧美激情| 一区二区三区四区激情视频| 最近中文字幕2019免费版| 女性被躁到高潮视频| 国产永久视频网站| 丝袜在线中文字幕| 成人国产av品久久久| 亚洲国产欧美在线一区| 考比视频在线观看| 黄色怎么调成土黄色| 成人免费观看视频高清| 精品久久久久久久久亚洲| 久久精品国产a三级三级三级| 黑人高潮一二区| 成人午夜精彩视频在线观看| 综合色丁香网| 人体艺术视频欧美日本| av在线老鸭窝| xxx大片免费视频| 热99久久久久精品小说推荐| 亚洲,一卡二卡三卡| 国产av码专区亚洲av| 丝袜脚勾引网站| 成人手机av| 丝瓜视频免费看黄片| 亚洲av福利一区| 国产午夜精品一二区理论片| 黄色毛片三级朝国网站| 精品熟女少妇av免费看| 麻豆精品久久久久久蜜桃| 久久久久精品久久久久真实原创| 黄色欧美视频在线观看| 成人漫画全彩无遮挡| 久久久国产精品麻豆| 中文字幕精品免费在线观看视频 | 久久久久人妻精品一区果冻| 国产白丝娇喘喷水9色精品| 婷婷色综合www| 亚洲一区二区三区欧美精品| 熟妇人妻不卡中文字幕| 一边亲一边摸免费视频| 日本黄色日本黄色录像| 大香蕉97超碰在线| 91国产中文字幕| 精品亚洲乱码少妇综合久久| 国产精品欧美亚洲77777| 久久久久久久久久成人| 最近手机中文字幕大全| 亚洲精品久久久久久婷婷小说| 亚洲人成网站在线播| 大码成人一级视频| 在线播放无遮挡| 国产成人免费无遮挡视频| 国产成人精品久久久久久| 青春草国产在线视频| 国产伦精品一区二区三区视频9| 欧美精品高潮呻吟av久久| 国产精品三级大全| 少妇高潮的动态图| 国产精品久久久久久精品电影小说| 如日韩欧美国产精品一区二区三区 | 亚洲中文av在线| 国产精品嫩草影院av在线观看| 在线观看免费日韩欧美大片 | 久久久精品94久久精品| 国产白丝娇喘喷水9色精品| a级毛片黄视频| 亚洲精品日韩av片在线观看| 久久久久久久亚洲中文字幕| 在线观看国产h片| 日韩熟女老妇一区二区性免费视频| 在现免费观看毛片| 亚洲天堂av无毛| 丝袜在线中文字幕| 国产精品国产三级国产av玫瑰| 久久毛片免费看一区二区三区| 观看美女的网站| 欧美三级亚洲精品| 亚洲成人一二三区av| 日韩大片免费观看网站| 色5月婷婷丁香| av电影中文网址| 超色免费av| 99久久人妻综合| 大码成人一级视频| 国产一区二区三区综合在线观看 | 国产精品麻豆人妻色哟哟久久| 成人漫画全彩无遮挡| 欧美日韩综合久久久久久| 欧美精品亚洲一区二区| 搡女人真爽免费视频火全软件| 久久这里有精品视频免费| 久久 成人 亚洲| 中文天堂在线官网| 免费黄网站久久成人精品| 一级a做视频免费观看| 少妇高潮的动态图| 国产黄色视频一区二区在线观看| 亚洲av成人精品一二三区| 久久久精品免费免费高清| 91精品伊人久久大香线蕉| 久久热精品热| 亚洲av在线观看美女高潮| 亚洲精品国产色婷婷电影| 国产高清不卡午夜福利| 亚洲精品第二区| 亚洲综合色惰| 国产毛片在线视频| 最近手机中文字幕大全| 如日韩欧美国产精品一区二区三区 | 日本免费在线观看一区| 亚洲av综合色区一区| 大码成人一级视频| 免费大片黄手机在线观看| av女优亚洲男人天堂| 国产国语露脸激情在线看| 精品亚洲成a人片在线观看| 亚洲av福利一区| 少妇被粗大的猛进出69影院 | 色婷婷av一区二区三区视频| 丝袜喷水一区| 亚洲精品色激情综合| 久久久精品免费免费高清| 美女xxoo啪啪120秒动态图| 欧美人与善性xxx| 久久国产亚洲av麻豆专区| 成人亚洲欧美一区二区av| 2021少妇久久久久久久久久久| 人妻夜夜爽99麻豆av| 免费黄色在线免费观看| 免费人妻精品一区二区三区视频| 亚洲国产欧美日韩在线播放| 视频区图区小说| 亚洲国产毛片av蜜桃av| 夫妻午夜视频| 亚洲性久久影院| 少妇猛男粗大的猛烈进出视频| 九九在线视频观看精品| 久久久久网色| 亚洲一区二区三区欧美精品| 超碰97精品在线观看| 亚洲美女视频黄频| 18+在线观看网站| 婷婷色综合www| 日韩中字成人| av视频免费观看在线观看| 亚洲婷婷狠狠爱综合网| av播播在线观看一区| 亚洲三级黄色毛片| 91精品国产国语对白视频| 最新的欧美精品一区二区| 亚洲国产毛片av蜜桃av| 中文字幕av电影在线播放| 久久热精品热| 丁香六月天网| 91在线精品国自产拍蜜月| 日韩一本色道免费dvd| 精品亚洲成国产av| av国产精品久久久久影院| 亚洲精品自拍成人| 精品亚洲成国产av| 一区二区三区四区激情视频| 亚洲av中文av极速乱| 亚洲av成人精品一区久久| 在线观看免费高清a一片| 国产黄色免费在线视频| 午夜影院在线不卡| 毛片一级片免费看久久久久| 久久久午夜欧美精品| 精品久久久噜噜| 99久久综合免费| 国产精品一国产av| 久久婷婷青草| av电影中文网址| 看非洲黑人一级黄片| 80岁老熟妇乱子伦牲交| 午夜老司机福利剧场| 日韩中字成人| a级片在线免费高清观看视频| 国产老妇伦熟女老妇高清|